Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
SE |
|
T
|
THC Farmaceuticals Inc
OTC:CBDG
|
US |
|
Lalique Group SA
SIX:LLQ
|
CH |
|
Eagle High Plantations Tbk PT
IDX:BWPT
|
ID |
|
Magnet Forensics Inc
TSX:MAGT
|
CA |
Wall Street
Price Targets
SOBI Price Targets Summary
Swedish Orphan Biovitrum AB (publ)
According to Wall Street analysts, the average 1-year price target for
SOBI
is 445.37 SEK
with a low forecast of 311.08 SEK and a high forecast of 525 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SOBI's stock price target?
Price Target
445.37
SEK
According to Wall Street analysts, the average 1-year price target for
SOBI
is 445.37 SEK
with a low forecast of 311.08 SEK and a high forecast of 525 SEK.
What is Swedish Orphan Biovitrum AB (publ)'s Revenue forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
Swedish Orphan Biovitrum AB (publ)'s revenue is
21%.
The projected
CAGR
for the next 3 years is
13%.
What is Swedish Orphan Biovitrum AB (publ)'s Operating Income forecast?
Projected CAGR
14%
The
compound annual growth rate
of Swedish Orphan Biovitrum AB (publ)'s operating income for the next 3 years is
14%.
What is Swedish Orphan Biovitrum AB (publ)'s Net Income forecast?
Projected CAGR
173%
For the last 14 years the
compound annual growth rate for
Swedish Orphan Biovitrum AB (publ)'s net income is
26%.
The projected
CAGR
for the next 3 years is
173%.
